DURHAM, N.C., Sept. 19, 2017 -- Hatteras Venture Partners today announced it has named Sir Andrew Witty a Venture Partner. Mr. Witty will primarily focus on the strategic positioning of Hatteras and its portfolio companies in the ever-changing global health care industry. In addition, Mr. Witty will provide leadership counsel to Hatteras’ portfolio companies.
“We are thrilled to welcome Andrew to Hatteras Venture Partners. He brings unparalleled strategic insights and extensive industry experience to the firm and to our portfolio of emerging companies,” said Bob Ingram, General Partner of Hatteras Venture Partners. “Having had the pleasure of serving as Andrew’s mentor when I was CEO of Glaxo, it is hard to fully express my pride in having him join our dynamic team of company builders.”
Mr. Witty is also Chancellor of the University of Nottingham in England and serves on the boards of UnitedHealth Group and G1 Therapeutics, Inc. He was Chief Executive Officer of GlaxoSmithKline, plc (GSK) from 2008 until he retired in 2017. He joined GSK in 1985 and served in various senior roles in the UK, the U.S., South Africa and Singapore. In 2012, Mr. Witty was knighted for services to the economy and the UK pharmaceutical industry.
“Joining Hatteras gives me an exciting new opportunity to nurture amazing science for the benefit of patients,” said Mr. Witty. “The firm has an outstanding track record of finding novel science in the halls of academia and translating that science into successful companies. I cannot think of a better objective in the evolving health care environment than capitalizing this kind of innovation.”
About Hatteras Venture Partners
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, N.C., focused on seed and early stage opportunities in biopharmaceuticals, medical devices, diagnostics, healthcare IT and related opportunities in human medicine. The firm has approximately $450 million under management in five venture capital funds. Hatteras is led by a seasoned team of entrepreneurs and operators and has a long and successful track record of seed and early stage investing and company formation. To learn more about Hatteras, visit www.hatterasvp.com.
Contact:
Clay B. Thorp
General Partner
(919) 484-0730, ext. 240
[email protected]
Media Contact:
Heather Anderson
6 Degrees
(919) 827-5539
[email protected]


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Britain Courts Anthropic Amid US Defense Department Dispute
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 



